← Open Payments lookup

ANDREW SHEHATA: Open Payments

NPI 1669096574 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$501 in 30 payments from 10 companies in 2025. Trend: 2023 $284 · 2024 $462 · 2025 $501

Food & beverage: $501
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$153
Phathom Pharmaceuticals, Inc.7$70
Ardelyx, Inc.3$67
Aimmune Therapeutics, Inc.2$36
Takeda Pharmaceuticals U.S.A., Inc.2$35
Novo Nordisk Inc1$35
Janssen Biotech, Inc.2$35
Celltrion USA Inc.2$33
ABBVIE INC.1$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17

Products named: REZDIFFRA, VOQUEZNA, IBSRELA, ENTYVIO, Wegovy, TREMFYA, VEGZELMA, CREON.

Industry payments across NJ — which companies pay providers there.